The FDA is proposing to remove phenylephrine, a common decongestant found in many over-the-counter medications, due to lack of effectiveness.
Changes are coming to the cold and cough aisle of your local pharmacy: U.S. officials are moving to phase out the leading decongestant found in hundreds of over-the-counter medicines, concluding that it doesn’t actually relieve nasal congestion. Phenylephrine is used in popular versions of Sudafed, Dayquil and other medications, but experts have long questioned its effectiveness.
Last month the Food and Drug Administration formally proposed revoking its use in pills and liquid solutions, kicking off a process that’s likely to force drugmakers to remove or reformulate products. It’s a win for skeptical academics, including researchers at the University of Florida who petitioned the FDA to revisit the drug’s use in 2007 and again in 2015. For consumers it will likely mean switching to alternatives, including an older decongestant that was moved behind the pharmacy counter nearly 20 years ago. Doctors say Americans will be better off without phenylephrine, which is often combined with other medicines to treat cold, flu, fever and allergies. “People walk into the drugstore today and see 55,000 medicines on the shelf and they pick one that is definitely not going to work,” said Dr. Brian Schroer of the Cleveland Clinic. “You take away that option and it will be easier for them to self-direct toward products that really will help them.” Why is FDA doing this now? The FDA decision was expected after federal advisers last year voted unanimously that oral phenylephrine medications haven’t been shown to relieve congestion. Experts reviewed several recent, large studies indicating that phenylephrine was no better than a placebo at clearing nasal passageways. They also revisited studies from the 1960s and 1970s that supported the drug’s initial use, finding numerous flaws and questionable data. The panel’s opinion only applied to phenylephrine in oral medications, which account for roughly $1.8 billion in annual U.S. sale
FDA Phenylephrine Decongestant Over-The-Counter Medications Health
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Federal Judge: FDA Must Release Covid Vaccine “Emergency Use Authorization” Files by June 2025Judge Mark T. Pittman: “The COVID-19 pandemic is long passed and so has any legitimate reason for concealing from the American people the information relied upon by the government in approving the Pfizer vaccine.”
Read more »
McDonald’s E. coli outbreak: no more safety risk as U.S. FDA closes probeThe outbreak, which was first reported in October, sickened at least 104 people in 14 states, including one person who died and 34 who were hospitalized.
Read more »
Labor Department to Phase Out Sub-Minimum Wage Program for Workers with DisabilitiesThe Labor Department announces the phasing out of a program allowing employers to pay workers with disabilities less than the federal minimum wage. This move follows years of advocacy from disability rights groups and is part of President Biden’s campaign promises. However, the program's future remains uncertain due to potential legal challenges.
Read more »
After institutions come nations: Sovereign adoption is the next phase of Bitcoin’s evolutionThe Kitco News Team brings you the latest news, videos, analysis and opinions regarding Precious Metals, Crypto, Mining, World Markets and Global Economy.
Read more »
Ottawa Begins Final Phase of Three-Item Garbage Limit EnforcementThe City of Ottawa will start the final phase of enforcement for its new three-item garbage limit on Monday, leaving behind any extra items not in a yellow bag. Previously, all items were collected with a courtesy tag, and in November, one item was left with a tag if the limit was exceeded. Now, any extra garbage over the limit and not in a yellow bag will be left behind.
Read more »